Dr. Leo Kim is a retina surgeon and a member of the Retina Service who has extensive experience in the management of retinal diseases associated with neovascularization or angiogenesis. These include diseases such as retinal vein occlusions, diabetic retinopathy and age-related macular degeneration.
A clinician scientist, Dr. Kim focuses his research on understanding the mechanisms of vitreoretinal disease. He is particularly interested in the mechanisms of retinal toxicity associated with the use of systemic medications such as tamoxifen. In addition, he performs research on the molecular mechanisms of proliferative diabetic retinopathy, evaluating the cell biology of fibrovascular membranes and the genetics of PDR. He also performs translational research on the prognosis of non-exudative age-related macular degeneration.